Universus Photo Imagings Limited (NSE:UNIVPHOTO)
369.50
+30.77 (9.08%)
Feb 19, 2026, 3:29 PM IST
Universus Photo Imagings Revenue
Universus Photo Imagings had revenue of 38.40M INR in the quarter ending December 31, 2025, a decrease of -20.00%. This brings the company's revenue in the last twelve months to 186.06M, down -37.45% year-over-year. In the fiscal year ending March 31, 2025, Universus Photo Imagings had annual revenue of 245.96M, down -24.20%.
Revenue (ttm)
186.06M
Revenue Growth
-37.45%
P/S Ratio
19.93
Revenue / Employee
4.43M
Employees
42
Market Cap
3.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 245.96M | -78.52M | -24.20% |
| Mar 31, 2024 | 324.48M | -107.68M | -24.92% |
| Mar 31, 2023 | 432.16M | -129.46M | -23.05% |
| Mar 31, 2022 | 561.62M | 92.02M | 19.60% |
| Mar 31, 2021 | 469.60M | -154.55M | -24.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Nectar Lifesciences | 16.70B |
| Haleos Labs | 3.48B |
| Valiant Laboratories | 2.03B |
| Bafna Pharmaceuticals | 1.47B |